vs

Side-by-side financial comparison of Krispy Kreme, Inc. (DNUT) and Harmony Biosciences Holdings, Inc. (HRMY). Click either name above to swap in a different company.

Krispy Kreme, Inc. is the larger business by last-quarter revenue ($392.4M vs $243.8M, roughly 1.6× Harmony Biosciences Holdings, Inc.). Harmony Biosciences Holdings, Inc. runs the higher net margin — 9.2% vs -7.1%, a 16.3% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs -2.9%). Harmony Biosciences Holdings, Inc. produced more free cash flow last quarter ($126.0M vs $27.9M). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs -5.9%).

Krispy Kreme, Inc. is an American multinational doughnut company and coffeehouse chain. Krispy Kreme was founded by Vernon Rudolph (1915–1973), who bought a yeast-raised recipe from a New Orleans chef, rented a building in 1937 in what is now historic Old Salem in Winston-Salem, North Carolina, and began selling to local grocery stores. Steady growth preceded an ambitious expansion as a public company in the period 2000 to 2016, which ultimately proved unprofitable. In 2016, the company retur...

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

DNUT vs HRMY — Head-to-Head

Bigger by revenue
DNUT
DNUT
1.6× larger
DNUT
$392.4M
$243.8M
HRMY
Growing faster (revenue YoY)
HRMY
HRMY
+24.0% gap
HRMY
21.1%
-2.9%
DNUT
Higher net margin
HRMY
HRMY
16.3% more per $
HRMY
9.2%
-7.1%
DNUT
More free cash flow
HRMY
HRMY
$98.1M more FCF
HRMY
$126.0M
$27.9M
DNUT
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
-5.9%
DNUT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DNUT
DNUT
HRMY
HRMY
Revenue
$392.4M
$243.8M
Net Profit
$-27.8M
$22.5M
Gross Margin
71.9%
Operating Margin
-1.9%
15.8%
Net Margin
-7.1%
9.2%
Revenue YoY
-2.9%
21.1%
Net Profit YoY
-23.8%
-54.6%
EPS (diluted)
$-0.18
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DNUT
DNUT
HRMY
HRMY
Q4 25
$392.4M
$243.8M
Q3 25
$375.3M
$239.5M
Q2 25
$379.8M
$200.5M
Q1 25
$375.2M
$184.7M
Q4 24
$404.0M
$201.3M
Q3 24
$379.9M
$186.0M
Q2 24
$438.8M
$172.8M
Q1 24
$442.7M
$154.6M
Net Profit
DNUT
DNUT
HRMY
HRMY
Q4 25
$-27.8M
$22.5M
Q3 25
$-19.4M
$50.9M
Q2 25
$-435.3M
$39.8M
Q1 25
$-33.3M
$45.6M
Q4 24
$-22.4M
$49.5M
Q3 24
$39.6M
$46.1M
Q2 24
$-5.5M
$11.6M
Q1 24
$-8.5M
$38.3M
Gross Margin
DNUT
DNUT
HRMY
HRMY
Q4 25
71.9%
Q3 25
75.1%
Q2 25
81.0%
Q1 25
82.7%
Q4 24
73.0%
Q3 24
77.0%
Q2 24
81.4%
Q1 24
82.2%
Operating Margin
DNUT
DNUT
HRMY
HRMY
Q4 25
-1.9%
15.8%
Q3 25
-1.9%
27.3%
Q2 25
-114.4%
24.0%
Q1 25
-5.4%
30.4%
Q4 24
-2.8%
27.7%
Q3 24
-4.2%
33.2%
Q2 24
1.6%
12.4%
Q1 24
2.7%
33.7%
Net Margin
DNUT
DNUT
HRMY
HRMY
Q4 25
-7.1%
9.2%
Q3 25
-5.2%
21.2%
Q2 25
-114.6%
19.8%
Q1 25
-8.9%
24.7%
Q4 24
-5.6%
24.6%
Q3 24
10.4%
24.8%
Q2 24
-1.3%
6.7%
Q1 24
-1.9%
24.8%
EPS (diluted)
DNUT
DNUT
HRMY
HRMY
Q4 25
$-0.18
$0.38
Q3 25
$-0.11
$0.87
Q2 25
$-2.55
$0.68
Q1 25
$-0.20
$0.78
Q4 24
$-0.13
$0.85
Q3 24
$0.23
$0.79
Q2 24
$-0.03
$0.20
Q1 24
$-0.05
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DNUT
DNUT
HRMY
HRMY
Cash + ST InvestmentsLiquidity on hand
$42.4M
$775.3M
Total DebtLower is stronger
$911.9M
$163.7M
Stockholders' EquityBook value
$650.1M
$870.2M
Total Assets
$2.6B
$1.3B
Debt / EquityLower = less leverage
1.40×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DNUT
DNUT
HRMY
HRMY
Q4 25
$42.4M
$775.3M
Q3 25
$30.7M
$672.6M
Q2 25
$21.3M
$565.3M
Q1 25
$18.7M
$507.0M
Q4 24
$29.0M
$467.2M
Q3 24
$25.4M
$410.5M
Q2 24
$28.6M
$346.9M
Q1 24
$33.1M
$372.4M
Total Debt
DNUT
DNUT
HRMY
HRMY
Q4 25
$911.9M
$163.7M
Q3 25
$906.2M
$168.5M
Q2 25
$889.4M
$172.1M
Q1 25
$935.0M
$175.7M
Q4 24
$844.5M
$179.3M
Q3 24
$804.6M
$182.8M
Q2 24
$895.0M
$186.4M
Q1 24
$881.8M
$190.0M
Stockholders' Equity
DNUT
DNUT
HRMY
HRMY
Q4 25
$650.1M
$870.2M
Q3 25
$670.3M
$835.1M
Q2 25
$693.6M
$773.1M
Q1 25
$1.1B
$720.5M
Q4 24
$1.1B
$659.2M
Q3 24
$1.2B
$596.8M
Q2 24
$1.1B
$538.6M
Q1 24
$1.2B
$515.4M
Total Assets
DNUT
DNUT
HRMY
HRMY
Q4 25
$2.6B
$1.3B
Q3 25
$2.6B
$1.2B
Q2 25
$2.6B
$1.1B
Q1 25
$3.1B
$1.1B
Q4 24
$3.1B
$999.2M
Q3 24
$3.1B
$928.1M
Q2 24
$3.2B
$858.4M
Q1 24
$3.2B
$847.0M
Debt / Equity
DNUT
DNUT
HRMY
HRMY
Q4 25
1.40×
0.19×
Q3 25
1.35×
0.20×
Q2 25
1.28×
0.22×
Q1 25
0.85×
0.24×
Q4 24
0.74×
0.27×
Q3 24
0.68×
0.31×
Q2 24
0.79×
0.35×
Q1 24
0.76×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DNUT
DNUT
HRMY
HRMY
Operating Cash FlowLast quarter
$45.0M
$126.2M
Free Cash FlowOCF − Capex
$27.9M
$126.0M
FCF MarginFCF / Revenue
7.1%
51.7%
Capex IntensityCapex / Revenue
4.4%
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$-64.0M
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DNUT
DNUT
HRMY
HRMY
Q4 25
$45.0M
$126.2M
Q3 25
$42.3M
$108.7M
Q2 25
$-32.5M
$79.3M
Q1 25
$-20.8M
$34.0M
Q4 24
$27.0M
$75.6M
Q3 24
$3.3M
$70.5M
Q2 24
$33.2M
$42.6M
Q1 24
$-17.7M
$31.1M
Free Cash Flow
DNUT
DNUT
HRMY
HRMY
Q4 25
$27.9M
$126.0M
Q3 25
$15.5M
$108.7M
Q2 25
$-60.8M
$79.3M
Q1 25
$-46.7M
$33.9M
Q4 24
$-6.9M
$75.0M
Q3 24
$-22.9M
$70.5M
Q2 24
$1.6M
$42.0M
Q1 24
$-46.8M
$31.1M
FCF Margin
DNUT
DNUT
HRMY
HRMY
Q4 25
7.1%
51.7%
Q3 25
4.1%
45.4%
Q2 25
-16.0%
39.6%
Q1 25
-12.5%
18.3%
Q4 24
-1.7%
37.3%
Q3 24
-6.0%
37.9%
Q2 24
0.4%
24.3%
Q1 24
-10.6%
20.1%
Capex Intensity
DNUT
DNUT
HRMY
HRMY
Q4 25
4.4%
0.0%
Q3 25
7.1%
0.0%
Q2 25
7.4%
0.0%
Q1 25
6.9%
0.1%
Q4 24
8.4%
0.3%
Q3 24
6.9%
0.0%
Q2 24
7.2%
0.4%
Q1 24
6.6%
0.0%
Cash Conversion
DNUT
DNUT
HRMY
HRMY
Q4 25
5.61×
Q3 25
2.14×
Q2 25
1.99×
Q1 25
0.75×
Q4 24
1.53×
Q3 24
0.08×
1.53×
Q2 24
3.68×
Q1 24
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons